The Tritium agreement is good until March 2023 and is exclusive so we should see more orders. In my view, as long as we provided a quality product at a competitive price then there’s no reason for Tritium to self manufacture.
The $20m USD order is a big buy signal for me and I’ve bought in today. The second half of FY22 should be strong and first half of FY23 as well just with this order alone.
looking forward to the half year results this week and hopefully some forward guidance
- Forums
- ASX - By Stock
- RFT
- Ann: Product Purchase Orders from Tritium Pty Ltd
Ann: Product Purchase Orders from Tritium Pty Ltd, page-295
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFT (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.002(33.3%) |
Mkt cap ! $11.05M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $14.07K | 1.958M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 6423388 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 3696856 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5423388 | 0.006 |
11 | 2427942 | 0.005 |
2 | 1000000 | 0.004 |
2 | 765001 | 0.003 |
1 | 1000000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 3696856 | 11 |
0.009 | 1583070 | 6 |
0.010 | 343189 | 2 |
0.011 | 1359000 | 4 |
0.012 | 72003 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RFT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online